Related Experiment Video
Updated: Mar 24, 2026
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia
Insights
Recent advancements in chronic lymphocytic leukaemia (CLL) treatment led to revised Dutch guidelines. The CLL working group updated recommendations based on new studies and expert consensus.
Area of Science:
- Hematology
- Oncology
- Clinical Guidelines
Background:
- Chronic lymphocytic leukaemia (CLL) treatment has seen significant progress.
- Existing Dutch guidelines required updating to reflect recent therapeutic advancements.
Purpose of the Study:
- To revise the Dutch guidelines for chronic lymphocytic leukaemia (CLL) management.
- To incorporate new research findings and expert opinions into clinical practice.
Main Methods:
- Review of recent studies on CLL treatment.
- Consensus-building among members of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) CLL working group.
- Revision of existing Dutch clinical guidelines.
Main Results:
- Updated guidelines for CLL patient treatment.
- Incorporation of novel therapeutic strategies and evidence-based recommendations.
Conclusions:
- The revised Dutch guidelines provide an updated framework for managing chronic lymphocytic leukaemia.
- These updated guidelines aim to optimize patient care and outcomes in CLL.
Abstract:
In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group.
